Alkermes plc is a biopharmaceutical company headquartered in Dublin, Ireland, focused on the innovative research, development, and commercialization of therapies to meet significant unmet medical needs across diverse therapeutic areas, including neuroscience and oncology. With a robust pipeline of products and a commitment to improving patient outcomes, Alkermes leverages its proprietary technologies to enhance drug delivery and therapeutic effectiveness. The company's strategic collaborations and global reach position it as a key player in the biopharmaceutical industry, serving patients in the United States and beyond.